Marker Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.47 -0.05 (-3.29%) USD | NASDAQ | Dec 30, 16:00

1.45 -0.02 (-1.36%) After-Hours: 07:39

View Net Non-Operating Interest Income Expense (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Neurocrine Biosciences, Inc.	--
AIM ImmunoTech, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
Armata Pharmaceuticals, Inc.	Upgrade